Arabic Arabic English English French French German German
dark

Innovative, faster and more cost-effective technology identifies drug that inhibits SARS-CoV-2 growth in lab setting

Much progress has been made on the development of vaccines aiming at triggering human immunity to SARS-CoV-2, the virus that causes COVID-19. In addition, researchers at Baylor College of Medicine are involved in the development of antiviral drugs to treat infected individuals. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Researchers discover way to switch on and speed up tendon healing

Next Post

Protecting Lithium Battery-Powered Medical Devices During Transit

Related Posts
Total
0
Share